# Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis

> **NCT01818544** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 94 (actual)

## Conditions studied

- Bronchiectasis

## Interventions

- **DRUG:** BAY85-8501
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01818544
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2015-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01818544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01818544, "Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01818544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*